Case number 1:23-cv-00022
Astellas Pharma Inc. et al v. Qilu Pharma, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 27, 2023 | 20 | FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,842,780. (mpb) (Entered: 09/28/2023) (1) |
| Sep 27, 2023 | 19 | STIPULATED ORDER OF DISMISSAL (CASE CLOSED) Signed by Judge Joseph F. Bataillon on 9/27/2023. (mpb) (Entered: 09/28/2023) (1) |
| Sep 26, 2023 | 18 | STIPULATION of Dismissal by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 09/26/2023) (2) |
| Aug 29, 2023 | 17 | NOTICE requesting Clerk to remove Nitya Anand as co-counsel.. (Joyce, Alexandra) (Entered: 08/29/2023) (2) |
| May 26, 2023 | N/A | Pro Hac Vice Attorney Jayita Guhaniyogi for Astellas Ireland Co., Ltd. Astellas Pharma Global Development, Inc., Astellas Pharma Inc.,J Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(smg) (Entered: 05/26/2023) (0) |
| May 26, 2023 | N/A | Pro Hac Vice Attorney Nitya Anand for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(smg) (Entered: 05/26/2023) (0) |
| May 23, 2023 | N/A | Pro Hac Vice Attorney Connor S. Romm for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(mkr) (Entered: 05/23/2023) (0) |
| May 23, 2023 | N/A | Pro Hac Vice Attorney Simon D. Roberts and Rodney D. Swartz, II for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00022-JFB-CJB, 1:23-cv-00486-JFB-CJB(mpb) (Entered: 05/23/2023) (0) |
| May 22, 2023 | 16 | SO ORDERED D.I. 15 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 5/22/2023. (dlb) (Entered: 05/22/2023) (0) |
| May 17, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications for Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz)(Joyce, Alexandra) (Entered: 05/17/2023) (Certifications for Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya) (7) |
| May 17, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications for Simon D. Roberts, Jason A. Leonard, Jayita Guhaniyogi, Nitya Anand, Vincent Li, Connor S. Romm, and Rodney Swartz)(Joyce, Alexandra) (Entered: 05/17/2023) (Main Document) (2) |
| Apr 13, 2023 | N/A | SO ORDERED D.I. 10 Stipulation filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. Ordered by Judge Christopher J. Burke on 4/13/2023. (dlb) (Entered: 04/13/2023) (0) |
| Apr 12, 2023 | N/A | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) (Entered: 04/12/2023) (0) |
| Apr 12, 2023 | 13 | SO ORDERED, re 12 Unopposed MOTION for Extension of Time to File Answer re 1 Complaint. Signed by Judge Joseph F. Bataillon on 4/12/2023. (twk) (Entered: 04/12/2023) (1) |
| Apr 12, 2023 | 14 | ORAL ORDER Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Christopher J. Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 04/12/23. (AEV) (Entered: 04/12/2023) (0) |
| Apr 12, 2023 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (dlb) (Entered: 04/12/2023) (0) |
| Apr 6, 2023 | 12 | Unopposed MOTION for Extension of Time to File Answer re 1 Complaint, - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 04/06/2023) (3) |
| Mar 13, 2023 | 11 | Unopposed MOTION for Extension of Time to File Answer re 1 Complaint, - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/13/2023) (2) |
| Jan 23, 2023 | 10 | STIPULATION regarding Venue and Personal Jurisdiction by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 01/23/2023) (4) |
| Jan 18, 2023 | N/A | Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) (Entered: 01/18/2023) (0) |
| Jan 18, 2023 | 9 | WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.: For Qilu Pharma, Inc. waiver sent on 1/12/2023, answer due 3/13/2023. (Silver, Daniel) (Entered: 01/18/2023) (1) |
| Jan 18, 2023 | 8 | WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.: For Qilu Pharmaceutical Co., Ltd. waiver sent on 1/12/2023, answer due 3/13/2023. (Silver, Daniel) (Entered: 01/18/2023) (1) |
| Jan 10, 2023 | 7 | Summons Issued as to Qilu Pharmaceutical Co., Ltd. on 1/10/2023. (apk) (Entered: 01/10/2023) (2) |
| Jan 10, 2023 | 6 | Summons Issued as to Qilu Pharma, Inc. on 1/10/2023. (apk) (Entered: 01/10/2023) (2) |
| Jan 10, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holdings, Inc. for Astellas Pharma Global Development, Inc., Astellas Pharma Inc.; Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (apk) (Entered: 01/10/2023) (3) |
| Jan 10, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Qilu Pharma, Inc., Qilu Pharmaceutical Co., Ltd. ( Filing fee $ 402, receipt number ADEDC-4040541.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(apk) (Entered: 01/10/2023) (Exhibit A) (19) |
| Jan 10, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Qilu Pharma, Inc., Qilu Pharmaceutical Co., Ltd. ( Filing fee $ 402, receipt number ADEDC-4040541.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(apk) (Entered: 01/10/2023) (Civil Cover Sheet) (3) |
| Jan 10, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,842,780. (apk) (Entered: 01/10/2023) (1) |
| Jan 10, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/28/2022. Date of Expiration of Patent: 9/28/2029.Thirty Month Stay Deadline: 5/28/2025. (apk) (Entered: 01/10/2023) (3) |
| Jan 10, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 01/10/2023) (3) |
| Jan 10, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Qilu Pharma, Inc., Qilu Pharmaceutical Co., Ltd. ( Filing fee $ 402, receipt number ADEDC-4040541.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(apk) (Entered: 01/10/2023) (Main Document) (14) |
